TransCode Therapeutics, Inc. (RNAZ)
NASDAQ: RNAZ · Real-Time Price · USD
0.4440
+0.0440 (11.00%)
Apr 25, 2025, 12:46 PM EDT - Market open

TransCode Therapeutics Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2018 - 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2018 - 2019
Cash & Equivalents
5.812.774.9720.830.83
Upgrade
Short-Term Investments
--0.010.010
Upgrade
Cash & Short-Term Investments
5.812.774.9820.840.83
Upgrade
Cash Growth
109.97%-44.40%-76.11%2406.60%306.52%
Upgrade
Prepaid Expenses
0.340.551.381.46-
Upgrade
Other Current Assets
0.941.141.020.44-
Upgrade
Total Current Assets
7.094.467.3822.730.83
Upgrade
Property, Plant & Equipment
0.090.60.210.21-
Upgrade
Long-Term Deferred Charges
----0.22
Upgrade
Other Long-Term Assets
0.110.11---
Upgrade
Total Assets
7.295.177.5922.941.06
Upgrade
Accrued Expenses
2.713.054.352.50.4
Upgrade
Current Portion of Leases
0.040.41---
Upgrade
Current Unearned Revenue
0.030.03-0.03-
Upgrade
Total Current Liabilities
2.773.494.352.530.4
Upgrade
Long-Term Debt
----2.09
Upgrade
Long-Term Leases
-0.04---
Upgrade
Other Long-Term Liabilities
6.54---1.97
Upgrade
Total Liabilities
9.313.534.352.534.46
Upgrade
Common Stock
00000
Upgrade
Additional Paid-In Capital
61.1848.0631.1130.710.07
Upgrade
Retained Earnings
-63.2-46.42-27.87-10.31-3.46
Upgrade
Comprehensive Income & Other
-----0.01
Upgrade
Shareholders' Equity
-2.021.643.2420.4-3.41
Upgrade
Total Liabilities & Equity
7.295.177.5922.941.06
Upgrade
Total Debt
0.040.45--2.09
Upgrade
Net Cash (Debt)
5.772.324.9820.84-1.26
Upgrade
Net Cash Growth
149.15%-53.45%-76.11%--
Upgrade
Net Cash Per Share
16.21----
Upgrade
Filing Date Shares Outstanding
23.340.18---
Upgrade
Total Common Shares Outstanding
1.030.02---
Upgrade
Working Capital
4.320.963.0320.20.43
Upgrade
Book Value Per Share
-1.9686.30---
Upgrade
Tangible Book Value
-2.021.643.2420.4-3.41
Upgrade
Tangible Book Value Per Share
-1.9686.30---
Upgrade
Machinery
0.360.380.350.25-
Upgrade
Updated Nov 14, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q